PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BGAIX vs. BIOPX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


BGAIXBIOPX
YTD Return22.26%36.45%
1Y Return33.82%46.50%
3Y Return (Ann)-14.96%-1.16%
5Y Return (Ann)6.85%15.59%
10Y Return (Ann)10.48%9.82%
Sharpe Ratio1.682.22
Sortino Ratio2.252.85
Omega Ratio1.291.40
Calmar Ratio0.631.32
Martin Ratio7.6312.18
Ulcer Index4.56%3.81%
Daily Std Dev20.64%20.86%
Max Drawdown-61.84%-67.79%
Current Drawdown-39.37%-4.90%

Correlation

-0.50.00.51.00.9

The correlation between BGAIX and BIOPX is 0.91, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

BGAIX vs. BIOPX - Performance Comparison

In the year-to-date period, BGAIX achieves a 22.26% return, which is significantly lower than BIOPX's 36.45% return. Over the past 10 years, BGAIX has outperformed BIOPX with an annualized return of 10.48%, while BIOPX has yielded a comparatively lower 9.82% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
20.42%
21.51%
BGAIX
BIOPX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BGAIX vs. BIOPX - Expense Ratio Comparison

BGAIX has a 0.90% expense ratio, which is lower than BIOPX's 1.31% expense ratio.


BIOPX
Baron Opportunity Fund
Expense ratio chart for BIOPX: current value at 1.31% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.31%
Expense ratio chart for BGAIX: current value at 0.90% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.90%

Risk-Adjusted Performance

BGAIX vs. BIOPX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Baron Global Advantage Fund (BGAIX) and Baron Opportunity Fund (BIOPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BGAIX
Sharpe ratio
The chart of Sharpe ratio for BGAIX, currently valued at 1.68, compared to the broader market0.002.004.001.68
Sortino ratio
The chart of Sortino ratio for BGAIX, currently valued at 2.25, compared to the broader market0.005.0010.002.25
Omega ratio
The chart of Omega ratio for BGAIX, currently valued at 1.29, compared to the broader market1.002.003.004.001.29
Calmar ratio
The chart of Calmar ratio for BGAIX, currently valued at 0.63, compared to the broader market0.005.0010.0015.0020.0025.000.63
Martin ratio
The chart of Martin ratio for BGAIX, currently valued at 7.63, compared to the broader market0.0020.0040.0060.0080.00100.007.63
BIOPX
Sharpe ratio
The chart of Sharpe ratio for BIOPX, currently valued at 2.22, compared to the broader market0.002.004.002.22
Sortino ratio
The chart of Sortino ratio for BIOPX, currently valued at 2.85, compared to the broader market0.005.0010.002.85
Omega ratio
The chart of Omega ratio for BIOPX, currently valued at 1.40, compared to the broader market1.002.003.004.001.40
Calmar ratio
The chart of Calmar ratio for BIOPX, currently valued at 1.32, compared to the broader market0.005.0010.0015.0020.0025.001.32
Martin ratio
The chart of Martin ratio for BIOPX, currently valued at 12.18, compared to the broader market0.0020.0040.0060.0080.00100.0012.18

BGAIX vs. BIOPX - Sharpe Ratio Comparison

The current BGAIX Sharpe Ratio is 1.68, which is comparable to the BIOPX Sharpe Ratio of 2.22. The chart below compares the historical Sharpe Ratios of BGAIX and BIOPX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.00JuneJulyAugustSeptemberOctoberNovember
1.68
2.22
BGAIX
BIOPX

Dividends

BGAIX vs. BIOPX - Dividend Comparison

Neither BGAIX nor BIOPX has paid dividends to shareholders.


TTM202320222021202020192018201720162015
BGAIX
Baron Global Advantage Fund
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.30%
BIOPX
Baron Opportunity Fund
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BGAIX vs. BIOPX - Drawdown Comparison

The maximum BGAIX drawdown since its inception was -61.84%, smaller than the maximum BIOPX drawdown of -67.79%. Use the drawdown chart below to compare losses from any high point for BGAIX and BIOPX. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-39.37%
-4.90%
BGAIX
BIOPX

Volatility

BGAIX vs. BIOPX - Volatility Comparison

The current volatility for Baron Global Advantage Fund (BGAIX) is 4.39%, while Baron Opportunity Fund (BIOPX) has a volatility of 5.78%. This indicates that BGAIX experiences smaller price fluctuations and is considered to be less risky than BIOPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%JuneJulyAugustSeptemberOctoberNovember
4.39%
5.78%
BGAIX
BIOPX